Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older. - Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy Early Stage, Low Volume in Prostate Cancer.
Prostate Biopsy, Focal Brachytherapy , Assessment of QOL
City of Hope Medical Center - Recruiting 18 years or older. - Randomized Phase II Trial of Sipuleucel T Immunotherapy Preceded by Sensitizing Radiation Therapy and Sipuleucel-T Alone in Patients With Castrate Resistant Metastatic Prostate Cancer.
University of Southern California - Recruiting 18 years or older. - A Phase II Clinical Trial of Cabazitaxel Plus Prednisone With Octreotide in the Treatment of Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel.
University of California, San Francisco - Recruiting N/A or older. - Pre-Operative Gleason Score and PSA and Clinical Stage in Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer.
medical chart review; questionnaire administration; quality-of-life assessment; brachytherapy; radiation therapy
National Cancer Institute (NCI) - Recruiting 18 years or older. - Androgen Receptor Modulation Phase II, Randomized Study of MK-2206 - Bicalutamide Combination in Patients With Rising PSA at High-Risk of Progression After Primary Therapy.
National Cancer Institute (NCI) - Recruiting 18 years or older. - Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy.
cholecalciferol; genistein; placebo; laboratory biomarker analysis; pharmacological study
National Cancer Institute (NCI) - Recruiting N/A to 74 years. - Multicentre Randomized Trial Assessing the Efficacy of a Short Neoadjuvant and Concomitant Hormone Therapy to an Exclusive Curative Cornformational Radiotherapy of Locolized Prostate Cancer With Intermediate Prognosis.